Ref.: BL-RE-093247Manufacturer ref.: EH82RBX10 10 x 96 tests
€4,995.00 excl. VAT
Human CD229 quantitates human CD229 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD229.
Accession number
Ai893573; CD229; CDABP0070; Ly-9 cell surface molecule; hly9; Lgp100; Ly9; Ly-9; lymphocyte antigen 9; mLY9; RP11-312J72; lymphocyte signaling activation molecule 3; member of the SLAM 3 family; SLAMF3; T100 ; lymphocyte surface antigen T Ly-9
Dose range
80 to 20 000 pg/ml
Sensitivity of the dosage
80 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human CD229 quantitates human CD229 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD229.
Human CD229 quantitates human CD229 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD229.
CD229 (Ly9) is a cell surface receptor of the CD150 family, which also includes, among other things, CD48 and CD224. The receptors in this family regulate cytokine production and cytotoxicity of lymphocytes and NK cells. High levels of CD229 are observed on T and B cells, where their expression increases during maturation. It is absent on granulocytes, dendritic cells derived from bone marrow, platelets, and erythrocytes. CD229 has also been reported on monocytes and NK cells from mice. CD229 interacts homophilously through its N-terminal end domain and is located at the site of contact between T-cells and the antigen presenting B-cells during the formation of antigen-dependent immune synapses.
Sensitivity
Sensitivity of dosage: 80 pg/ml.
Measurement range
Dose range: 80 to 20,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Target
Target: CD229 (Ly9).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17844170
Specifications
Accession number
Ai893573; CD229; CDABP0070; Ly-9 cell surface molecule; hly9; Lgp100; Ly9; Ly-9; lymphocyte antigen 9; mLY9; RP11-312J72; lymphocyte signaling activation molecule 3; member of the SLAM 3 family; SLAMF3; T100 ; lymphocyte surface antigen T Ly-9